UBS Group
CC icon

UBS Group’s Chemours CC Stock Holding History

UBS Group’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-46,100
Closed -$1.7M – 9502
2023
Q2 		$1.7M Hold
46,100
– – ﹤0.01% 3692
2023
Q1 		$1.38M Buy
+46,100
New +$1.52M ﹤0.01% 3813
2017
Q2 		– Sell
-128,200
Closed -$4.94M – 7691
2017
Q1 		$4.94M Buy
+128,200
New +$3.86M ﹤0.01% 2094

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's CC Position: Q1 2026 in Review

UBS Group reduced its Chemours (CC) stake by 23% in Q1 2026, selling an estimated $14.2M and leaving 2,767,806 shares worth $61M. The position accounts for 0.01% of the portfolio, ranked #1443.

UBS Group first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $75.3M in Q3 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • UBS Group held 2,767,806 shares of Chemours worth $61M as of Q1 2026.
  • UBS Group sold 817,393 Chemours shares in Q1 2026, an estimated $14.2M.
  • Chemours made up 0.01% of UBS Group's portfolio in Q1 2026, its #1443 holding.
  • UBS Group first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • UBS Group's Chemours position peaked at $75.3M in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.